1st Quarter - Report

THE ADVOCACY GROUP for EMERGENT BIOSOLUTIONS

Period 1st Quarter 2017 Filed Apr 20, 2017 Signed by GEORGE A. RAMONAS

Official filing
Firm
THE ADVOCACY GROUP
Client
EMERGENT BIOSOLUTIONS
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE

Homeland Security HOM

FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE

Disaster Planning/Emergencies DIS

FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: Homeland Security, Dept of (DHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.